{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:33:26Z","timestamp":1790087606033,"version":"4.0.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Vasculogenic Mimicry (VM) can reduce the efficacy of anti-angiogenesis and promote distant metastasis in hepatocellular carcinoma (HCC). Our previous studies have found that <jats:italic>Celastrus orbiculatus<\/jats:italic> extract (COE) can inhibit the VM formation in HCC by reducing EphA2 expression. However the underlying mechanism related to EphA2 in VM formation is unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Purpose<\/jats:title><jats:p>This study aimed to confirm that EphA2 is one of the potential targets of COE, and to explore the effect of EphA2 in VM formation in hypoxia context in HCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>TCM Systems Pharmacology database and proteomics analysis were used to explore the key targets of COE in HCC treatment. CD31-PAS double staining and VE-CAD staining were used to indicate vasculogenic mimicry. The localization of EphA2 and VE-CAD was examined through fluorescent microscopy. CCK8 assay, cell invasion assay, and tube formation assay were used to indicate the formation of VM under hypoxic conditions. The regulatory relationship of EphA2 upstream and downstream molecules were evaluated through COIP and Western Blot. The nude mouse xenograft tumor models were used to observe the VM formation after knocking down or overexpressing EphA2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>EphA2 is identified to the target of COE, and the driving gene of HCC. In HCC surgical specimens, EphA2 expression is closely associated with the VM formation of HCC. COE-regulated EphA2 is involved in hypoxia-induced VM formation in HCC cells in vitro. EphA2 is regulated by HIF directly or indirectly by C-MYC. Overexpression of EphA2 can promote the VM formation of HCC in nude mice, while knocking down EphA2 can inhibit the VM formation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>EphA2, as a target of COE, plays a crucial regulatory role in the formation of vasculogenic mimicry in HCC, involving upstream HIF\/MYC transcriptional promotion and downstream PI3K\/FAK\/VE-CAD expression regulation.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1421470","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:47:22Z","timestamp":1720586842000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["COE targets EphA2 to inhibit vasculogenic mimicry formation induced by hypoxia in hepatocellular carcinoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Jue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ke","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Ke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10555-022-10067-x","article-title":"Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry","volume":"41","author":"Andreucci","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41401-019-0268-y","article-title":"EPHA2 feedback activation limits the response to PDE\u03b4 inhibition in KRAS-dependent cancer cells","volume":"41","author":"Chen","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"619732","DOI":"10.3389\/fphar.2021.619732","article-title":"COE inhibits vasculogenic mimicry by targeting EphA2 in hepatocellular carcinoma, a research based on proteomics analysis","volume":"12","author":"Chu","year":"","journal-title":"Front. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"831941","DOI":"10.3389\/fphar.2021.831941","article-title":"Corrigendum: COE inhibits vasculogenic mimicry by targeting EphA2 in hepatocellular carcinoma, a research based on proteomics analysis","volume":"12","author":"Chu","year":"","journal-title":"Front. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41419-023-05666-7","article-title":"VE-Cadherin modulates \u03b2-catenin\/TCF-4 to enhance Vasculogenic Mimicry","volume":"14","author":"Delgado-Bellido","year":"2023","journal-title":"Cell Death Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"116363","DOI":"10.1016\/j.jep.2023.116363","article-title":"The anti-tumor effects of Celastrus orbiculatus Thunb. and its monomer composition: a review","volume":"310","author":"Feng","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.7150\/thno.72404","article-title":"Exosomal EPHA2 derived from highly metastatic breast cancer cells promotes angiogenesis by activating the AMPK signaling pathway through Ephrin A1-EPHA2 forward signaling","volume":"12","author":"Han","year":"2022","journal-title":"Theranostics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.2825356","article-title":"A novel putative tyrosine kinase receptor encoded by the eph gene","volume":"238","author":"Hirai","year":"1987","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11418-019-01326-3","article-title":"Cytotoxic abietane and kaurane diterpenoids from Celastrus orbiculatus","volume":"73","author":"Jiang","year":"2019","journal-title":"J. Nat. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jep.2017.07.007","article-title":"COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling","volume":"208","author":"Jue","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2018.12.011","article-title":"S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties","volume":"444","author":"Li","year":"2019","journal-title":"Cancer Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"889799","DOI":"10.3389\/fphar.2022.889799","article-title":"Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1111\/jcmm.13283","article-title":"MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer","volume":"21","author":"Li","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1038\/s41388-021-01786-6","article-title":"EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis","volume":"40","author":"Mao","year":"2021","journal-title":"Oncogene"},{"key":"B15","first-page":"5039","article-title":"Targeting the PI3K-Akt-mTOR signaling pathway involved in vasculogenic mimicry promoted by cancer stem cells","volume":"13","author":"Murai","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1007\/s11655-011-0819-7","article-title":"Celastrus orbiculatus extract inhibits tumor angiogenesis by targeting vascular endothelial growth factor signaling pathway and shows potent antitumor activity in hepatocarcinomas in vitro and in vivo","volume":"18","author":"Qian","year":"2012","journal-title":"Chin. J. Integr. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.tranon.2019.04.022","article-title":"Limitations of anti-angiogenic treatment of tumors","volume":"12","author":"Ribatti","year":"2019","journal-title":"Transl. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"130084","DOI":"10.1016\/j.bbagen.2022.130084","article-title":"Vasculogenic mimicry: a dynamic event of malignancy","volume":"1866","author":"Simizu","year":"2022","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/CMAR.S414487","article-title":"The synergy of gene targeting drug Icaritin soft capsule with immunomodulator and tace brings new hope for drug combination in patients with advanced liver cancer: a case report and literature review","volume":"15","author":"Tang","year":"2023","journal-title":"Cancer Manag. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10663","DOI":"10.2147\/OTT.S227215","article-title":"Cobalt chloride induced apoptosis by inhibiting GPC3 expression via the HIF-1\u03b1\/c-Myc Axis in HepG2 cells","volume":"12","author":"Tong","year":"2019","journal-title":"Onco Targets Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"107805","DOI":"10.1016\/j.pharmthera.2021.107805","article-title":"Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - interest in making it a therapeutic target","volume":"223","author":"Treps","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/MO:18:4:243","article-title":"Treatment resistance of solid tumors: role of hypoxia and anemia","volume":"18","author":"Vaupel","year":"2001","journal-title":"Med. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"13322","DOI":"10.1038\/ncomms13322","article-title":"Vasculogenic mimicry in small cell lung cancer","volume":"7","author":"Williamson","year":"2016","journal-title":"Nat. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"5059","DOI":"10.21873\/anticanres.14509","article-title":"Cetyltrimethylammonium bromide suppresses the migration and invasion of hepatic mahlavu cells by modulating fibroblast growth factor signaling","volume":"40","author":"Wu","year":"2020","journal-title":"Anticancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"933051","DOI":"10.3389\/fendo.2022.933051","article-title":"Bisphenol A promotes the progression of colon cancer through dual-targeting of NADPH oxidase and mitochondrial electron-transport chain to produce ROS and activating HIF-1\u03b1\/VEGF\/PI3K\/AKT Axis","volume":"13","author":"Xia","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ccell.2019.04.007","article-title":"Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes","volume":"35","author":"Xue","year":"2019","journal-title":"Cancer Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"111900","DOI":"10.1016\/j.ecoenv.2021.111900","article-title":"Gold nanoparticles synergize with bacterial lipopolysaccharide to enhance class A scavenger receptor dependent particle uptake in neutrophils and augment neutrophil extracellular traps formation","volume":"211","author":"Yang","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"B28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.20892\/j.issn.2095-3941.2022.0449","article-title":"Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies","volume":"20","author":"Yao","year":"2023","journal-title":"Cancer Biol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1111\/jcmm.12862","article-title":"Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype","volume":"20","author":"Yao","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1749-6632.2009.05043.x","article-title":"An essential role of the HIF-1alpha-c-Myc axis in malignant progression","volume":"1177","author":"Yoo","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180741","article-title":"Down-regulation of HIF-1\u03b1 inhibits the proliferation, migration, and invasion of gastric cancer by inhibiting PI3K\/AKT pathway and VEGF expression","volume":"38","author":"Zhang","year":"2018","journal-title":"Biosci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13058-021-01488-7","article-title":"Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins","volume":"23","author":"Zhang","year":"2021","journal-title":"Breast Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbrc.2021.01.064","article-title":"Cyclin-dependent kinase 5 controls vasculogenic mimicry formation in non-small cell lung cancer via the FAK-AKT signaling pathway","volume":"546","author":"Zhou","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1421470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T04:47:25Z","timestamp":1720586845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1421470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":33,"alternative-id":["10.3389\/fphar.2024.1421470"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1421470","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,10]]},"article-number":"1421470"}}